bronchodilator

1. Methods The data of201 suspicious asthmatic patients with normal pulmonary ventilation function examined by spirometry and bronchodilator reversibility testing were retrospectively analyzed.
   方法回顾性分析201例疑似哮喘患者支气管舒张试验的数据。
2. A bronchodilator ( trade names Ventolin or Proventil) used for asthma and emphysema and other lung conditions; available in oral or inhalant forms; side effects are tachycardia and shakiness.
   用于哮喘、肺气肿和其他肺病的药物；口服或吸入；副作用是心跳过速。
3. A bronchodilator ( trade name Slo-Bid) used to treat asthma and bronchitis and emphysema.
   一种用来治疗哮喘、支气管炎和肺气肿的支气管扩张剂（商标是SloBid）。
4. The significance of bronchodilator reversibility testing in suspicious asthmatic patients with normal pulmonary ventilation function
   支气管舒张试验对肺通气功能正常的疑似哮喘患者应用的意义
5. Differences of Flow and Volume Responses after Inhalation of Bronchodilator in Patients with Mild to Very Severe COPD
   不同严重程度COPD患者吸入支气管舒张剂后的流速和容积反应
6. An inhaled bronchodilator ( trade name Atrovent).
   一种吸入性支气管扩张剂（商标是Atrovent）。
7. Conclusions: Ambroxol is only effective as bronchodilator to certain degree, and its effect relies heavily on the role of being expectorant.
   结论：盐酸氨溴索仅有部分的支气管扩张作用，并且很大程度上依赖于其祛痰作用。
8. I will use the steroid inhaler one hour before I use the bronchodilator.
   我将先使用类固醇喷雾剂，一小时后再使用支气管扩张药物喷雾剂。
9. Conclusions: These bronchodilator agents routinely used can improve the symptom of dyspnea in severe COPD patients at stable stage, but the effects of combined administration of fenoterol and ipratropium bromide are obviously more satisfactory.
   结论：对重度COPD稳定期患者在常规治疗下雾化吸入支气管扩张剂能改善其临床气促症状，而联合应用非诺特罗和异丙托溴铵疗效优于任何一药单独应用。
10. It is necessary to promote the application of pulmonary function test, especially the bronchodilator test and long term response to bronchodilator and inhaled Corticosteroid, in order to improve the proper diagnosis and treatment of asthma and COPD in elderly.
    有必要普及肺功能检查，尤其是支气管舒张剂吸入试验和治疗后的肺功能动态观察，提高老年哮喘的诊断水平。
11. Bronchodilator treatment and deaths from asthma: case-control study
    支气管扩张剂治疗与哮喘死亡：病例对照研究
12. Airway resistances can be improved by bronchodilator.
    支气管扩张剂能改善气道阻力。
13. Oxygen saturation as a predictor of pro-longed, frequent bronchodilator therapy in children with acute asthma
    血氧饱和度作为急性哮喘患儿治疗中延长频繁使用支气管扩张剂时间的预测指标
14. Objective: To investigate the effect of Nitric Oxide ( NO) as a bronchodilator on releasing bronchoconstriction and improving pulmonary gas exchange through the experimental research, and investigate the effect of inhaling NO and Helium Oxygen mixture ( Heliox) simultaneously on asthmatic dogs.
    本研究的目的即通过动物实验，观察一氧化氮作为支气管扩张剂解除气道痉挛的作用及对肺内气体交换的影响，以及同时吸入一氧化氮和氦氧混合气对哮喘的作用。
15. Methods: Twenty-eight patients with COPD with respiratory failure were examined for blood oxygen saturation and blood gas analysis before and after application of noninvasive ventilation combined with nebulization of bronchodilator in addition to the routine drug therapy.
    方法：观察28例COPD伴呼吸衰竭患者在常规药物治疗的基础上应用无创通气结合雾化吸入治疗前后的血气分析变化，经统计学处理后比较通气前后各指标的差异。
16. Conclusion The increase of IC hasn't a certain relation with the result of bronchodilator test.
    结论IC的增加与舒张试验的阳性和阴性结果没有必然的关联，可作为独立指标。
17. Conclusion It is an effective and noninvasive clinical method of differential diagnosis in bronchial asthma patients with chest tightness suggestive of CHD to employ peak flow meter with PEF test for bronchodilator response.
    结论采用微型高峰流速仪做支气管舒张试验测定PEF，是临床对哮喘类似冠心病胸闷鉴别诊断的无创、安全、方便、价廉、有效的筛选方法。
18. Therefore, in suspected case of asthma in the elderly, routine examination of both bronchodilator test and bronchial provocation test should be performed, preferably the later, in order to benefit the diagnosis of asthma in the elderly.
    对可疑老年哮喘的病人，应常规行支气管扩张试验，有条件者可作支气管激发试验，以提高老年哮喘的诊断率，以便及时治疗。
19. Clinical Differential Diagnosis in Bronchial Asthma Patients with Chest Tightness like Coronary Heart Disease by Bronchodilator Test
    支气管舒张试验对类似冠心病胸闷症状的支气管哮喘的鉴别诊断
20. Airway responsiveness and reversibility of airway obstruction were determined in 31 patients with asthma by bronchial histamine provocation test and bronchodilator test.
    以支气管组胺激发试验和支气管扩张剂试验对31例缓解期哮喘进行了气道反应性和气道阻塞可逆性测定。
21. BHR was found in 79. 6% patients with chronic cough, 62. 7% with dyspnea, and that the total effective rate was 92. 4% in those under bronchodilator therapy.
    慢性咳嗽病人中气道高反应性（BHR）者占79.6%，胸闷病人中BHR者占62.7%，其中BHR者接受支气管扩张剂治疗，总有效率达92.4%。
22. Methods: Selective pulmonary function test, bronchodilator test and bronchial provocation test were performed in 63 cases of clinically diagnosed asthmatics in the elderly and in 113 cases of asthma in young age ( < 30 year of age) as control group for comparison.
    方法：对临床诊断为哮喘的63例老年病人进行基础肺功能、支气管扩张试验（支扩试验）、支气管激发试验（激发试验）等项检查，并与137例30岁以下的青年哮喘患者进行比较。
23. To compare consistency of 200 μ g albuterol and 80 μ g Ipratropium Bromide as bronchodilator in pulmonary function test in COPD patients.
    目的：比较慢性阻塞性肺疾病（COPD）患者吸入200μg沙丁胺醇与吸入80μg溴化异丙托品进行支气管舒张试验结果的一致性。
24. Objective: To assess the changes of the membrane diffusing capacity ( Dm) and pulmonary capillary blood volume ( Vc) in different stages of COPD and the effect of the bronchodilator inhalation on diffusing capacity ( DLCO) and Dm in COPD patients.
    目的：探索慢性阻塞性肺疾病（COPD）缓解期不同分级的患者膜弥散功能（Dm）和肺血管床容量（Vc）的变化，以及使用支气管扩张剂后通气功能改善对Dm和Vc的影响。
25. CVA is treated with bronchodilator, steroid, Leukotriene receptor antagonist, aminophylline.
    西医治疗以支气管扩张剂、糖皮质激素、白三烯受体拮抗剂等药物为主。
26. Comparing the treatment groups were significantly better than the control group, P ≤ 0.01.Conclusion: Chronic bronchodilator therapy group for remission ( partial liver yang hyperactivity card) improvement in clinical symptoms than the control group, and safety, is worthy of clinical application.
    两组对比治疗组明显优于对照组，P≤0.01。结论：治疗组针对支气管扩张慢性缓解期（肝阳偏亢证）在中医症状改善方面明显优于对照组，且安全，值得临床推广应用。
27. In addition to the role of bronchodilator, theophylline can also stimulate the respiratory center, lower pulmonary artery resistance, which combined have the COPD patients with pulmonary heart disease useful.
    茶碱除有支气管扩张作用外，还可刺激呼吸中枢、降低肺动脉阻力，这对于合并有肺心病的COPD患者有益。
28. Patients were randomly assigned to treatment group and control group, 20 cases of the control group, only conventional treatment, including antibiotic therapy, oxygen therapy, expectorant and bronchodilator.
    并将患者随机分配到治疗组和对照组中，对照组20例，仅采用常规治疗，包括抗生素治疗、氧疗、祛痰、支气管舒张剂或吸入糖皮质激素。

noun

1. a drug that relaxes and dilates the bronchial passageways and improves the passages of air into the lungs